CIA
PRAH

CSat Investment Advisory’s PRA Health Sciences, Inc. PRAH Stock Holding History

CSat Investment Advisory’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-333
Closed -$34K – 1058
2020
Q3 		$34K Buy
333
+41
+14% +$4.18K ﹤0.01% 738
2020
Q2 		$28K Buy
292
+37
+15% +$3.44K ﹤0.01% 761
2020
Q1 		$21K Buy
255
+44
+21% +$4.29K ﹤0.01% 718
2019
Q4 		$23K Buy
211
+26
+14% +$2.67K 0.01% 751
2019
Q3 		$18K Buy
185
+26
+16% +$2.58K 0.01% 745
2019
Q2 		$16K Buy
+159
New +$15.2K 0.01% 746

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

CSat Investment Advisory's PRAH Position: Q4 2020 in Review

CSat Investment Advisory sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2020, closing a stake of 333 shares — an estimated $34K sold.

CSat Investment Advisory first reported a position in PRAH in Q2 2019 and held it in 6 quarters. The position peaked at $34K in Q3 2020. 289 funds tracked by Wall St. Rank hold PRAH as of Q4 2020.

  • CSat Investment Advisory reported no remaining PRA Health Sciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 333 PRA Health Sciences, Inc. shares in Q4 2020, an estimated $34K.
  • CSat Investment Advisory first reported a position in PRA Health Sciences, Inc. in Q2 2019 and held it in 6 quarters.
  • CSat Investment Advisory's PRA Health Sciences, Inc. position peaked at $34K in Q3 2020.
  • 289 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.